Trial Profile
Phase II Study of Pemetrexed Monotherapy in Patients With Platinum-resistant Squamous Cell Carcinoma of Head and Neck.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 14 Apr 2011 New trial record